Effect of cherry consumption on blood pressure: a systematic review and meta-analysis of randomized controlled trials.
- 2022-02
- Diabetes & metabolic syndrome 16(2)
- Omid Eslami
- Fatemeh Khorramrouz
- Abed Ghavami
- Saeedeh Hajebi Khaniki
- Farzad Shidfar
- PubMed: 35108661
- DOI: 10.1016/j.dsx.2022.102409
Study Design
- Type
- Meta-Analysis
- Sample size
- n = 201
- Population
- 201 participants (from 7 RCTs)
- Methods
- Systematic review and meta-analysis of RCTs; searched PubMed, Scopus, Embase, and Web of Science up to December 2020
Background and aims
The present systematic review and meta-analysis aimed to summarize the findings of randomized controlled trials (RCTs) evaluating the effect of tart and sweet cherries on systolic and diastolic blood pressure (SBP and DBP).Methods
PubMed, Scopus, Embase, and Web of Science were searched to acquire the RCTs up to December 2020.Results
Seven RCTs comprising 201 participants were included. The meta-analysis showed that cherry supplementation does not lead to a significant decrease in SBP or DBP.Conclusions
Incorporating cherries into the diet has no significant effect on blood pressure.Research Insights
cherry supplementation does not lead to a significant decrease in SBP or DBP.
- Effect
- Neutral
- Effect size
- Small
cherry supplementation does not lead to a significant decrease in SBP or DBP.
- Effect
- Neutral
- Effect size
- Small